Reta

Retatrutide is a synthetic peptide designed to target the GLP-1 (Glucagon-Like Peptide-1) receptor for the treatment of obesity and related metabolic disorders. Normally, when we eat, natural hormones called GIP and GLP-1 are released by the gut. These hormones increase insulin release, suppress appetite, slow gastric emptying, and increase the feeling of fullness. Retatrutide works like our natural hormones GIP and GLP-1 by activating the GIP and GLP-1 receptors.